论文信息 - Phase II study of alisertib as a single agent in recurrent or progressive atypical teratoid rhabdoid tumors. - 字舞流文

Phase II study of alisertib as a single agent in recurrent or progressive atypical teratoid rhabdoid tumors.

D. Ellison | A. Gajjar | B. Orr | S. Partap | G. Robinson | C. Stewart | R. Tatevossian | J. Crawford | Amy A. Smith | A. Onar-Thomas | C. Billups | A. Broniscer | Z. Patay | L. Kilburn | P. Baxter | O. Campagne | S. Upadhyaya